GOUT RELIEF 3310-S- medicago sativa whole chicory root capsule 
Bispit Canada Ltd.

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

85631-006-01-Gout Relief 3310-S-NEW

MEDICAGO SATIVA WHOLE 20.00%
CHICORY ROOT 23.00%
GLUCOSAMINE HYDROCHLORIDE 10.00%
BUCKWHEAT 7.00%
TEA LEAF 5.00%
MORUS ALBA LEAF 13.00%
LICORICE 0.20%
FU LING 2.00%
COIX LACRYMA-JOBI SEED 8.00%

This product has a significanteffect on gout, crystal deposits,and hyperuricemia;
elt has an auxiliary effectof mitigating kidney stonesand bladder stones

Keep out of reach of children

The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;

Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus

Do not use if seal is broken.

Do not eat freshness packet enclosed.

Keep out of direct sunlight, high temperature, and humidity.

Store in a cool, dry place.

For your health, please read the followingcarefully
1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;
5. This product certainly has significant effect on gout,crystallization and hyperuricemia;

This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones

labeling

GOUT RELIEF 3310-S 
medicago sativa whole chicory root capsule
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:85631-006
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
COIX LACRYMA-JOBI SEED (UNII: 4Q4V6NTZ1F) (COIX LACRYMA-JOBI SEED - UNII:4Q4V6NTZ1F) COIX LACRYMA-JOBI SEED104 mg  in 1.3 g
MEDICAGO SATIVA WHOLE (UNII: DJO934BRBD) (MEDICAGO SATIVA WHOLE - UNII:DJO934BRBD) MEDICAGO SATIVA WHOLE260 mg  in 1.3 g
BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3) BUCKWHEAT91 mg  in 1.3 g
TEA LEAF (UNII: GH42T47V24) (TEA LEAF - UNII:GH42T47V24) TEA LEAF65 mg  in 1.3 g
MORUS ALBA LEAF (UNII: M8YIA49Q2P) (MORUS ALBA LEAF - UNII:M8YIA49Q2P) MORUS ALBA LEAF169 mg  in 1.3 g
CHICORY ROOT (UNII: 090CTY533N) (CHICORY ROOT - UNII:090CTY533N) CHICORY ROOT299 mg  in 1.3 g
FU LING (UNII: XH37TWY5O4) (FU LING - UNII:XH37TWY5O4) FU LING26 mg  in 1.3 g
GLUCOSAMINE HYDROCHLORIDE (UNII: 750W5330FY) (GLUCOSAMINE - UNII:N08U5BOQ1K) GLUCOSAMINE HYDROCHLORIDE130 mg  in 1.3 g
LICORICE (UNII: 61ZBX54883) (LICORICE - UNII:61ZBX54883) LICORICE2.6 mg  in 1.3 g
Inactive Ingredients
Ingredient NameStrength
MALTOSYL-ISOMALTOTETRAOSE (UNII: B9HR7A9UFR)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)  
Product Characteristics
ColorwhiteScorescore with uneven pieces
ShapeCAPSULESize20mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:85631-006-0160 in 1 BOTTLE09/01/2025
11.3 g in 1 CAPSULE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic09/01/2025
Labeler - Bispit Canada Ltd. (243332192)
Registrant - Bispit Canada Ltd. (243332192)

Revised: 9/2025
Document Id: 3dbf3436-16ba-b793-e063-6394a90a1e71
Set id: 3dbf3436-16b9-b793-e063-6394a90a1e71
Version: 1
Effective Time: 20250901
 
Bispit Canada Ltd.